London & Capital Asset Management Ltd

Position in LLY — ELI LILLY & Co

CIK 1767559 London, X0

Position in LLY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,383,267

+$2,021,798 QoQ

Shares Held

1,987

+405.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#2,338

of 4,604 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

London & Capital Asset Management Ltd holds $7,884,378 across 5 Drug Manufacturers - General names. LLY ranks #2 (30.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	9,513	$2,416,016
2	LLY	ELI LILLY & Co This page	1,987	$2,383,267
3	MRK	Merck & Co., Inc.	10,993	$1,412,600
4	ABBV	AbbVie Inc.	5,460	$1,373,954
5	GILD	Gilead Sciences, Inc.	2,363	$298,541

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,383,267	1,987	+405.6%	Shares	Sole	2026-08-12
2026-03-31	$361,469	393	-79.0%	Shares	Sole	2026-05-15
2025-12-31	$2,012,875	1,873	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.